Please wait





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox not checked   Rule 13d-1(c)
Checkbox checked   Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person:  Number of shares beneficially owned reported in Rows 5 and 7 consists of shares held of record by Medtronic Global Holdings S.C.A., an indirect, wholly-owned subsidiary of Medtronic plc. Percentage reported in Row 11 is based on 280,819,988 shares of common stock outstanding as of April 11, 2026, as reported in the Issuer's Form 10-Q filed with the Securities and Exchange Commission on April 17, 2026.


SCHEDULE 13G



 
Medtronic plc
 
Signature:/s/ Brian Sandstrom
Name/Title:Brian Sandstrom/VP, Chief Corporate and Securities Counsel
Date:05/06/2026